Drug Database
Back to search

Poland· PL-100465267

Clabilla Gem

A bilastin product containing bilastinum, registered in Poland by Glenmark Pharmaceuticals s.r.o.. The same ATC class is registered in 11 of our 19 countries.

ATC R06AX29

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedClabilla GemATCR06AX29REGISTER NO.PL-100465267PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about bilastinumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Bilastin is registered in 11 of 19 countries.

Countries holding a registration under ATC R06AX29 (bilastin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose
Search bilastin products by name

Bilastin · ATC R06AX29

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of bilastin costs, country by country.

Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.14 in France to $0.45 in Switzerland — a ×3.3 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Bilastin · price per daily dose (20 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.45
  • FR France$0.14
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Bilastinum
Manufacturer
Glenmark Pharmaceuticals s.r.o.
Country
Poland (PL)
ATC code
R06AX29
ATC class
Bilastin
Defined daily dose
20 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991522902

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Bilastin in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bilastin products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Bilastin Hyperpoll, Bilastin Tiefenbacher
  • Belgium · Bellozal, Bilastine Ab
  • Bulgaria · Bilastine Stada, Биластин Мсн
  • Cyprus · Alivixa, Bilastine Delorbis
  • Czechia · Abisax, Bilastin Stada
  • Germany · Allegra Allergietabletten, Allegra Allergietabletten Kinder
  • Denmark · Bilastine Stada, Revitelle
  • Estonia · Bilastin, Bilastine Stada
  • Spain · Abisax, Abrilia
  • Finland · Bilastine Stada, Revitelle
  • France · Bilaska, Bilastine Arrow
  • United Kingdom (Northern Ireland) · Bilastine Medreich, Bilastine Milpharm
  • Greece · Bilargen, Bilastine Stada
  • Croatia · Actine, Nixar
  • Hungary · Bilastine Supremex, Bilastine Teva
  • Ireland · Bilastine Clonmel, Bilhista
  • Iceland · Bilaxten
  • Italy · Alyne, Ayrinal
  • Lithuania · Belargan, Bilastine Sandoz
  • Luxembourg · Bellozal, Bilastine Eurogenerics
  • Latvia · Bilastine Stada, Bilpexo
  • Malta · Alivixa, Bilastine Clonmel
  • Norway · Bilastine Stada, Zilas
  • Portugal · Aelardis, Alostine
  • Romania · Bilastină Gemax Pharma, Bilastină Msn
  • Sweden · Bilacina, Bilastin Teva
  • Slovenia · Bilador, Bilastin Stada
  • Slovakia · Abisax, Bilastin Stada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e61f6bd6-1809-44e2-b260-6d02bec9c5eb
GET /v1/drugs/e61f6bd6-1809-44e2-b260-6d02bec9c5eb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "20 mg",
  "packaging": "05909991522902 ¦ OTC ¦ 151514\n10 tabl.",
  "substance": "Bilastinum 20 mg",
  "common_name": "Bilastinum",
  "pl_product_id": "100465267",
  "pozwolenie_nr": "28034",
  "auth_procedure": "DCP",
  "authorisation_validity": "2028-09-29"
}
API referenceMCP serverPlans

See everything about bilastin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console